Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Moriarty

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
European Cells & Materials|February 1, 2020
Deriving a dose and regimen for anti-glucosaminidase antibody passive-immunisation for patients with Staphylococcus aureus osteomyelitisC C Lee, R D Southgate, C Jiao, et al.
Malaria Journal|November 4, 2021
Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018Catherine M Dentinger, Tovonahary Angelo Rakotomanga, Antsa Rakotondrandriana, et al.
Malaria Journal|October 3, 2021
In vivo efficacy and safety of artemether-lumefantrine and amodiaquine-artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018Abel Nhama, Lídia Nhamússua, Eusébio Macete, et al.
Drugs & Aging|July 5, 2021
A Propensity Score Matched Approach to Assess the Associations of Commonly Prescribed Medications with Fall Risk in a Large Harmonized Cohort of Older Ambulatory PersonsL J Seppala, B van de Loo, M Schut, et al.
Expert Opinion on Biological Therapy|August 10, 2024
Clinical management and innovation in fracture non-unionC Siverino, W-J Metsemakers, R Sutter, et al.
The American Journal of Tropical Medicine and Hygiene|November 4, 2025
Efficacy and Safety of Artesunate + Amodiaquine and Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Madagascar, 2020Aina Harimanana, Dina Ny Aina Liantsoa Randriamiarinjatovo, Tovonanahary Angelo Rakotomanga, et al.
Injury|September 5, 2017
Fracture-related infection: A consensus on definition from an international expert groupW J Metsemakers, M Morgenstern, M A McNally, et al.
Emerging Infectious Diseases|January 29, 2021
Use of US Public Health Travel Restrictions during COVID-19 Outbreak on Diamond Princess Ship, Japan, February-April 2020Alexandra M Medley, Barbara J Marston, Mitsuru Toda, et al.
The Lancet. Infectious Diseases|August 22, 2025
Efficacies of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trialMoses R Kamya, Joaniter I Nankabirwa, Chris Ebong, et al.
Malaria Journal|May 26, 2021
Therapeutic efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015-2016Youssouf Diarra, Oumar Koné, Lansana Sangaré, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
European Cells & Materials|February 1, 2020
Deriving a dose and regimen for anti-glucosaminidase antibody passive-immunisation for patients with Staphylococcus aureus osteomyelitisC C Lee, R D Southgate, C Jiao, et al.
Malaria Journal|November 4, 2021
Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018Catherine M Dentinger, Tovonahary Angelo Rakotomanga, Antsa Rakotondrandriana, et al.
Malaria Journal|October 3, 2021
In vivo efficacy and safety of artemether-lumefantrine and amodiaquine-artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018Abel Nhama, Lídia Nhamússua, Eusébio Macete, et al.
Drugs & Aging|July 5, 2021
A Propensity Score Matched Approach to Assess the Associations of Commonly Prescribed Medications with Fall Risk in a Large Harmonized Cohort of Older Ambulatory PersonsL J Seppala, B van de Loo, M Schut, et al.
Expert Opinion on Biological Therapy|August 10, 2024
Clinical management and innovation in fracture non-unionC Siverino, W-J Metsemakers, R Sutter, et al.
The American Journal of Tropical Medicine and Hygiene|November 4, 2025
Efficacy and Safety of Artesunate + Amodiaquine and Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Madagascar, 2020Aina Harimanana, Dina Ny Aina Liantsoa Randriamiarinjatovo, Tovonanahary Angelo Rakotomanga, et al.
Injury|September 5, 2017
Fracture-related infection: A consensus on definition from an international expert groupW J Metsemakers, M Morgenstern, M A McNally, et al.
Emerging Infectious Diseases|January 29, 2021
Use of US Public Health Travel Restrictions during COVID-19 Outbreak on Diamond Princess Ship, Japan, February-April 2020Alexandra M Medley, Barbara J Marston, Mitsuru Toda, et al.
The Lancet. Infectious Diseases|August 22, 2025
Efficacies of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trialMoses R Kamya, Joaniter I Nankabirwa, Chris Ebong, et al.
Malaria Journal|May 26, 2021
Therapeutic efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015-2016Youssouf Diarra, Oumar Koné, Lansana Sangaré, et al.
Pageof 11